Kohei Shitara, Zev A. Wainberg, Josep Tabernero, Eric Van Cutsem, Clélia Coutzac, Christelle de la Fouchardière, Jeeyun Lee, Sun Young Rha, Yoon-Koo Kang, Philip Fanning, Grace An, Feng Jin, Alison J Forgie, Jaume Pons, Athanasios Tsiatis, Sophia Randolph, Keun-Wook Lee. "Final analysis of the randomized phase 2 part of the ASPEN-06 study: A phase 2/3 study of evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with HER2-overexpressing gastric/gastroesophageal cancer (GC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.332